Jie Shen

Jie Shen is a highly experienced professional with over 20 years of expertise in creating and implementing innovative solutions to enhance patient access to groundbreaking medicines.

As an agile leader, Jie Shen has a strong focus on delivering results, improving business performance through economic evidences, pricing strategies, business connectivity, and policy framework development.

Jie Shen possesses outstanding technical skills in areas such as value proposition, pricing, health technology assessment, health policy, and stakeholder partnerships.

Throughout his career, Jie Shen has successfully built high-performing market access and policy functions at various levels including country, region, and global settings.

His specialties include Market Access, Health Policy, Strategic & Operational Pricing, Health Technology Assessment, Government & Payer Partnerships, and developing access and policy functions and capabilities.

Jie Shen has vast experience in leading global, regional, and country teams, with a specific focus on regions like China, Japan, Europe, and Emerging Markets.

He has a strong background in transformative therapies and specialty care products.

Jie Shen's educational background includes a Distinguished Certificate from the University of York, an M.B.A from INSEAD, and a Bachelor's degree from the Shanghai International Studies University.

Professionally, Jie Shen has held key positions such as Vice President, Global Head of Payer Strategy, Specialty & Primary Care at GSK and Corporate Head of Value, Pricing & Access Policy at Novartis.

He also served as the Global Head of Market Access & Policy at Abbott Pharmaceuticals, Global Division Head of Market Access at sanofi-aventis, Senior Director of Market Access & Pricing at Biogen Idec Int'l GmbH, and held several other prominent roles at Novartis and Eli Lilly and Company.